H. Trinh

发表

Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records

J. Mazières, S. Mhatre, M. Bretscher, 2022, medRxiv.

Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population

S. Gale, K. Sarsour, A. Jahreis, 2019, Rheumatology and Therapy.

Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine Learning

Fredrik D. Johansson, D. Sontag, E. Losina, 2020, The Journal of Rheumatology.

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data

Gregory Riely, M. Bretscher, S. Mahrus, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development

Fredrik D. Johansson, D. Sontag, E. Losina, 2020, ACR open rheumatology.

Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients

E. Sokol, Z. Modrušan, S. Trabucco, 2020, Nature Communications.

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

J. Stone, J. Best, S. Gale, 2019, Rheumatology and Therapy.

Treatment patterns and outcomes for patients (pts) with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) in US clinical practice

M. Krebs, L. Polito, V. Smoljanović, 2019, Annals of Oncology.

Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK

S. Gale, S. Jick, K. Sarsour, 2018, Rheumatology and Therapy.

Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking.

J. Fanning, H. Trinh, C. Ott, 2004, American journal of obstetrics and gynecology.

Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC.

R. Doebele, N. Meropol, M. Krebs, 2021, Journal of comparative effectiveness research.

984P Relationship between RET fusion partner and treatment outcomes in patients (pts) with non-small cell lung cancer (NSCLC) from the phase I/II ARROW study and real-world data (RWD)

J. Mazières, G. Lopes, M. Nowicka, 2022, Annals of Oncology.